학술논문

Integrated genomic and molecular characterization of cervical cancer
Document Type
article
Author
Burk, Robert DChen, ZiguiSaller, CharlesTarvin, KatherineCarvalho, Andre LScapulatempo-Neto, CristovamSilveira, Henrique CFregnani, José HCreighton, Chad JAnderson, Matthew LCastro, PatriciaWang, Sophia SYau, ChristinaBenz, ChristopherRobertson, A GordonMungall, KarenLim, LynetteBowlby, ReanneSadeghi, SaraBrooks, DeniseSipahimalani, PayalMar, RichardAlly, AdrianClarke, AmandaMungall, Andrew JTam, AngelaLee, DarleneChuah, EricSchein, Jacqueline ETse, KaneKasaian, KatayoonMa, YussanneMarra, Marco AMayo, MichaelBalasundaram, MirunaThiessen, NinaDhalla, NoreenCarlsen, RebeccaMoore, Richard AHolt, Robert AJones, Steven JMWong, TinaPantazi, AngelikiParfenov, MichaelKucherlapati, RajuHadjipanayis, AngelaSeidman, JonathanKucherlapati, MelanieRen, XiaojiaXu, Andrew WYang, LixingPark, Peter JLee, SeminRabeno, BrendaHuelsenbeck-Dill, LoriBorowsky, MarkCadungog, MarkIacocca, MaryPetrelli, NicholasSwanson, PatriciaOjesina, Akinyemi ILe, XuanSandusky, GeorgeAdebamowo, Sally NAkeredolu, TeniolaAdebamowo, ClementReynolds, Sheila MShmulevich, IlyaShelton, CandaceCrain, DanielMallery, DavidCurley, ErinGardner, JohannaPenny, RobertMorris, ScottShelton, TroyLiu, JiaLolla, LaxmiChudamani, SudhaWu, YeBirrer, MichaelMcLellan, Michael DBailey, Matthew HMiller, Christopher AWyczalkowski, Matthew AFulton, Robert SFronick, Catrina CLu, CharlesMardis, Elaine RAppelbaum, Elizabeth LSchmidt, Heather KFulton, Lucinda ACordes, Matthew GLi, TiandaoDing, LiWilson, Richard KRader, Janet SBehmaram, BehnazUyar, DeniseBradley, William
Source
Nature. 543(7645)
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Immunology
Cervical Cancer
Cancer
Clinical Research
Human Genome
Sexually Transmitted Infections
Biotechnology
Genetics
2.1 Biological and endogenous factors
Aetiology
APOBEC-1 Deaminase
Adenocarcinoma
B7-H1 Antigen
Carcinoma
Squamous Cell
Caspase 8
DNA-Binding Proteins
Female
Genomics
HLA-A Antigens
Human papillomavirus 16
Humans
Keratins
Mitogen-Activated Protein Kinase Kinases
Molecular Targeted Therapy
Mutation
Nuclear Proteins
PTEN Phosphohydrolase
Phosphatidylinositol 3-Kinases
Programmed Cell Death 1 Ligand 2 Protein
Protein Serine-Threonine Kinases
Proteomics
Proto-Oncogene Proteins p21(ras)
RNA
Long Noncoding
Receptor
ErbB-3
Receptor
Transforming Growth Factor-beta Type II
Receptors
Transforming Growth Factor beta
Signal Transduction
Transcription Factors
Uterine Cervical Neoplasms
Virus Integration
Cancer Genome Atlas Research Network
Albert Einstein College of Medicine
Analytical Biological Services
Barretos Cancer Hospital
Baylor College of Medicine
Beckman Research Institute of City of Hope
Buck Institute for Research on Aging
Canada's Michael Smith Genome Sciences Centre
Harvard Medical School
Helen F. Graham Cancer Center &Research Institute at Christiana Care Health Services
HudsonAlpha Institute for Biotechnology
ILSbio
LLC
Indiana University School of Medicine
Institute of Human Virology
Institute for Systems Biology
International Genomics Consortium
Leidos Biomedical
Massachusetts General Hospital
McDonnell Genome Institute at Washington University
Medical College of Wisconsin
Medical University of South Carolina
Memorial Sloan Kettering Cancer Center
Montefiore Medical Center
NantOmics
National Cancer Institute
National Hospital
Abuja
Nigeria
National Human Genome Research Institute
National Institute of Environmental Health Sciences
National Institute on Deafness &Other Communication Disorders
Ontario Tumour Bank
London Health Sciences Centre
Ontario Tumour Bank
Ontario Institute for Cancer Research
Ontario Tumour Bank
The Ottawa Hospital
Oregon Health &Science University
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
SRA International
St Joseph's Candler Health System
Eli &Edythe L. Broad Institute of Massachusetts Institute of Technology &Harvard University
Research Institute at Nationwide Children's Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
University of Bergen
University of Texas MD Anderson Cancer Center
University of Abuja Teaching Hospital
University of Alabama at Birmingham
University of California
Irvine
University of California Santa Cruz
University of Kansas Medical Center
University of Lausanne
University of New Mexico Health Sciences Center
University of North Carolina at Chapel Hill
University of Oklahoma Health Sciences Center
University of Pittsburgh
University of São Paulo
Ribeir ão Preto Medical School
University of Southern California
University of Washington
University of Wisconsin School of Medicine &Public Health
Van Andel Research Institute
Washington University in St Louis
Receptor
erbB-3
General Science & Technology
Language
Abstract
Cervical cancer remains one of the leading causes of cancer-related deaths worldwide. Here we report the extensive molecular characterization of 228 primary cervical cancers, one of the largest comprehensive genomic studies of cervical cancer to date. We observed notable APOBEC mutagenesis patterns and identified SHKBP1, ERBB3, CASP8, HLA-A and TGFBR2 as novel significantly mutated genes in cervical cancer. We also discovered amplifications in immune targets CD274 (also known as PD-L1) and PDCD1LG2 (also known as PD-L2), and the BCAR4 long non-coding RNA, which has been associated with response to lapatinib. Integration of human papilloma virus (HPV) was observed in all HPV18-related samples and 76% of HPV16-related samples, and was associated with structural aberrations and increased target-gene expression. We identified a unique set of endometrial-like cervical cancers, comprised predominantly of HPV-negative tumours with relatively high frequencies of KRAS, ARID1A and PTEN mutations. Integrative clustering of 178 samples identified keratin-low squamous, keratin-high squamous and adenocarcinoma-rich subgroups. These molecular analyses reveal new potential therapeutic targets for cervical cancers.